Cognitive Functions Perceptual Disturbances

Conditions: Pancreatic Ductal Adenocarcinoma (PDAC); Family History of Pancreas Cancer; Genetic Testing; Multi-cancer Early Detection
Interventions: Behavioral: Telephone education session; Behavioral: Online educational materials
Sponsors: Brigham and Women’s Hospital; Pancreatic Cancer Action Network; Exact Science Corporation; Dana-Farber Cancer Institute; Winn Career Development Award
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Conditions: HER2-negative Breast Cancer; Hormone Receptor Positive Tumor; Advanced Breast Cancer; Metastatic Breast Cancer
Interventions: Device: TheraBionic P1
Sponsors: Barbara Ann Karmanos Cancer Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Conditions: Pancreatic Adenocarcinoma; Pancreatic Cancer; Pancreatic Adenosquamous Carcinoma
Interventions: Biological: Autologous DC Therapy
Sponsors: Diakonos Oncology Corporation; Baylor College of Medicine
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Conditions: Obesity or Overweight; Diabetes Mellitus, Type 2
Interventions: Drug: AZD6234; Drug: Placebo
Sponsors: AstraZeneca
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Conditions: Diabetes
Interventions: Procedure: Gut motility quantification using a capsule after initiating GLP-1RA therapy
Sponsors: The Cleveland Clinic; Atmo Biosciences Pty Ltd
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Conditions: Atherosclerosis; Cardiovascular Disease; Obesity; Hypertension; Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
Interventions: Drug: Clazakizumab; Drug: Placebo
Sponsors: Eli Lilly and Company
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.